% | $
Quotes you view appear here for quick access.

Osiris Therapeutics, Inc. Message Board

  • faosto faosto Aug 13, 2013 2:49 PM Flag

    Secondary on Its Way

    Let's hope that management only does a secondary only if the money runners can secure a good floor price, like $22 or $23/share. They will need to do one, no doubt, to secure an additional $100 million to operationalize their products. Better yet, I hope they sell to Smith and Nephew - a powerhouse in wound care and orthopedics for about $2 billion or more.

5.02+0.04(+0.80%)Jul 27 4:00 PMEDT